IL-21 enhances natural killer cell response to cetuximab-coated pancreatic tumor cells

PURPOSE: Alternative strategies to EGFR blockage by mAbs is necessary in order to improve the efficacy of therapy in patients with locally advanced or metastatic pancreatic cancer. One such strategy includes the use of NK cells to clear cetuximab-coated tumor cells, as need for novel therapeutic app...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Autores principales: McMichael, Elizabeth L., Jaime-Ramirez, Alena Cristina, Guenterberg, Kristan D., Luedke, Eric, Atwal, Lakhvir S., Campbell, Amanda R., Hu, Zhiwei, Tatum, Armika S., Kondadasula, Sri Vidya, Mo, Xiaokui, Tridandapani, Susheela, Bloomston, Mark, Ellison, E. Christopher, Williams, Terence M., Bekaii-Saab, Tanios, Carson, William E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241232/
https://ncbi.nlm.nih.gov/pubmed/27435400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares